Free Trial

Jasper Therapeutics (JSPR) Institutional Ownership

Jasper Therapeutics logo
$3.97 +0.05 (+1.28%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$4.14 +0.17 (+4.28%)
As of 04/17/2025 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)

Current
Institutional Ownership
Percentage
79.85%
Number of
Institutional Buyers
(last 12 months)
38
Total
Institutional Inflows
(last 12 months)
$61.80M
Number of
Institutional Sellers
(last 12 months)
17
Total
Institutional Outflows
(last 12 months)
$763.59M
Get JSPR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

JSPR Institutional Buying and Selling by Quarter

Jasper Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/17/2025Sowell Financial Services LLC20,825$90K0.0%-25.7%0.139%
3/24/2025Wellington Management Group LLP27,069$579K0.0%+13.9%0.180%
2/27/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208%
2/17/2025Woodline Partners LP245,676$5.25M0.0%-50.4%1.638%
2/17/2025Soleus Capital Management L.P.1,494,420$31.95M2.0%+11.2%9.962%
2/17/2025Tema Etfs LLC12,435$266K0.1%N/A0.083%
2/17/2025Stempoint Capital LP135,244$2.89M0.7%N/A0.902%
2/17/2025Integral Health Asset Management LLC650,000$13.90M1.2%+85.7%4.333%
2/17/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208%
2/17/2025Deutsche Bank AG170,695$3.65M0.0%+30.0%1.138%
2/17/2025Braidwell LP714,658$15.28M0.5%+47.9%4.764%
2/17/2025Bank of America Corp DE287,204$6.14M0.0%-11.9%1.915%
2/17/2025Allostery Investments LP22,000$470K0.5%N/A0.147%
2/17/2025Ally Bridge Group NY LLC122,424$2.62M2.2%-69.4%0.816%
2/14/2025Boxer Capital Management LLC350,000$7.48M0.6%N/A2.333%
2/14/2025Jane Street Group LLC10,852$232K0.0%-18.7%0.072%
2/14/2025Northern Trust Corp104,367$2.23M0.0%-2.4%0.696%
2/14/2025Propel Bio Management LLC20,000$428K0.4%N/A0.133%
2/14/2025T. Rowe Price Investment Management Inc.82,165$1.76M0.0%N/A0.548%
2/14/2025Rock Springs Capital Management LP463,088$9.90M0.4%+0.9%3.087%
2/13/2025Marshall Wace LLP77,722$1.66M0.0%+17.2%0.518%
2/13/2025Mariner LLC36,794$787K0.0%-12.8%0.245%
2/13/2025Barclays PLC18,334$392K0.0%+13.6%0.122%
2/13/2025Russell Investments Group Ltd.247,272$5.29M0.0%+16.9%1.648%
2/13/2025Wells Fargo & Company MN7,415$159K0.0%+106.7%0.049%
2/12/2025Wellington Management Group LLP27,069$579K0.0%+13.9%0.180%
2/12/2025Schroder Investment Management Group59,034$1.24M0.0%N/A0.394%
2/12/2025JPMorgan Chase & Co.5,165$110K0.0%-68.5%0.034%
2/11/2025EntryPoint Capital LLC10,431$223K0.1%N/A0.070%
2/11/2025Simplify Asset Management Inc.20,000$428K0.0%N/A0.133%
1/30/2025 Rhumbline Advisers14,761$316K0.0%+12.6%0.098%
12/26/2024JPMorgan Chase & Co.16,391$308K0.0%+239.8%0.109%
11/27/2024Franklin Resources Inc.579,636$10.90M0.0%-17.0%3.864%
11/19/2024Barclays PLC16,146$304K0.0%+320.7%0.108%
11/16/2024Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704%
11/15/2024Barclays PLC16,146$304K0.0%+320.7%0.107%
11/15/2024Jane Street Group LLC13,354$251K0.0%N/A0.088%
11/15/2024Wellington Management Group LLP23,759$447K0.0%N/A0.157%
11/15/2024State Street Corp214,883$4.04M0.0%+12.3%1.423%
11/15/2024Samsara BioCapital LLC584,642$11.00M2.1%+11.4%3.872%
Can you still profit from AI this year? (Read this ASAP) (Ad)

AI isn’t dead — it’s just getting started. Weiss Ratings — ranked #1 by both the SEC and the Wall Street Journal — just issued 3 new “Buy” signals on under-the-radar AI stocks. See the names and ticker symbols now (for free).

Missed Nvidia? These 3 Weiss picks could lead the next AI rally
11/15/2024Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365%
11/14/2024Braidwell LP483,300$9.09M0.3%N/A3.201%
11/14/2024Verition Fund Management LLC25,353$477K0.0%N/A0.168%
11/14/2024Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645%
11/14/2024MetLife Investment Management LLC6,874$129K0.0%+129.1%0.046%
11/13/2024Great Point Partners LLC322,380$6.06M1.8%-19.8%2.135%
11/13/2024BNP Paribas Financial Markets2,512$47K0.0%+208.6%0.017%
11/13/2024FMR LLC38,361$722K0.0%N/A0.254%
10/30/2024AlphaCentric Advisors LLC17,500$329K0.2%N/A0.116%
10/29/2024Fernwood Investment Management LLC52,897$995K0.3%+6.9%0.351%
10/16/2024Wolff Wiese Magana LLC3,146$59K0.0%N/A0.021%
8/14/2024Great Point Partners LLC402,015$9.13M1.7%-1.4%2.669%
8/14/2024Ally Bridge Group NY LLC218,614$4.96M3.0%-24.6%1.451%
8/8/2024American Century Companies Inc.14,204$322K0.0%+27.1%0.094%
8/1/2024 Rhumbline Advisers13,231$300K0.0%N/A0.088%
7/26/2024Bank of New York Mellon Corp32,579$740K0.0%N/A0.216%
5/29/2024Opaleye Management Inc.435,573$12.79M2.8%-89.1%2.892%
5/20/2024Virtu Financial LLC10,410$306K0.0%N/A0.069%
5/17/2024Ikarian Capital LLC105,175$3.09M0.3%N/A0.698%
5/16/2024Kingdon Capital Management L.L.C.497,000$14.59M1.6%-86.0%3.300%
5/14/2024Qiming U.S. Ventures Management LLC928,964$27.27M30.4%-89.1%6.168%
5/14/2024StemPoint Capital LP129,211$3.79M1.0%N/A0.858%
5/10/2024Vanguard Group Inc.612,745$17.99M0.0%-85.0%4.069%
5/8/2024Russell Investments Group Ltd.79,811$2.34M0.0%N/A0.530%
5/7/2024Concurrent Investment Advisors LLC20,409$599K0.0%N/A0.136%
5/3/2024Carlyle Group Inc.1,066,189$31.30M2.0%-87.8%7.080%
3/18/2024Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720%
2/15/2024Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717%
2/7/2024Ieq Capital LLC54,500$43K0.0%N/A0.488%
2/7/2024Monaco Asset Management SAM249,563$197K0.1%N/A2.236%
2/5/2024Fernwood Investment Management LLC494,706$390K0.1%+8.8%4.433%
11/13/2023Mariner LLC652,749$457K0.0%-8.7%0.589%
11/9/2023Cowen AND Company LLC200,393$140K0.0%N/A0.181%
11/8/2023Forefront Analytics LLC110,792$78K0.0%+59.7%0.100%
10/30/2023Summit Trail Advisors LLC65,000$46K0.0%N/A0.059%
8/15/2023Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874%
8/14/2023Jefferies Financial Group Inc.489,884$671K0.0%N/A0.444%
6/1/2023Prelude Capital Management LLC54,500$99K0.0%N/A0.049%
5/16/2023Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301%
5/16/2023BVF Inc. IL9,900,000$17.92M0.7%N/A9.051%
5/15/2023Affinity Asset Advisors LLC476,948$863K0.3%N/A0.436%
5/15/2023Kingdon Capital Management L.L.C.3,040,000$5.50M1.0%+463.0%2.779%
5/15/2023RTW Investments LP2,329,809$4.22M0.1%N/A2.130%
5/12/2023Forefront Analytics LLC30,290$55K0.0%-73.4%0.028%
5/5/2023Carlyle Group Inc.8,761,891$15.77M0.5%N/A8.011%
5/3/2023Jump Financial LLC33,074$60K0.0%N/A0.030%
4/25/2023Qiming U.S. Ventures Management LLC8,519,648$15.42M18.7%+45.6%7.789%
2/13/2023Forefront Analytics LLC114,000$55K0.0%-4.8%0.300%
2/7/2023Fernwood Investment Management LLC454,706$220K0.1%+53.1%1.197%
11/14/2022Forefront Analytics LLC119,800$94K0.1%+246.0%0.327%
Can you still profit from AI this year? (Read this ASAP) (Ad)

AI isn’t dead — it’s just getting started. Weiss Ratings — ranked #1 by both the SEC and the Wall Street Journal — just issued 3 new “Buy” signals on under-the-radar AI stocks. See the names and ticker symbols now (for free).

Missed Nvidia? These 3 Weiss picks could lead the next AI rally
11/9/2022Fernwood Investment Management LLC297,080$234K0.1%N/A0.810%
5/10/2022Sectoral Asset Management Inc.675,000$2.40M0.4%N/A1.782%
5/9/2022Forefront Analytics LLC32,550$118K0.0%N/A0.086%
4/27/2022Vahanian & Associates Financial Planning Inc.10,000$36K0.1%-60.0%0.026%
2/15/2022Kingdon Capital Management L.L.C.540,000$4.24M0.5%N/A1.427%
2/2/2022Grace Capital218,110$1.71M1.0%N/A0.576%
1/28/2022Vahanian & Associates Financial Planning Inc.25,000$196K0.2%N/A0.066%
11/16/2021Citadel Advisors LLC3,005,035$29.22M0.0%N/A8.228%
11/15/2021Tudor Investment Corp Et Al20,000$205K0.0%N/A0.055%
11/15/2021Abingworth LLP5,628,558$58.03M13.2%N/A15.412%
(Data available from 1/1/2016 forward)

JSPR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of JSPR shares?

During the previous two years, 62 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($31.95M), Carlyle Group Inc. ($31.30M), Qiming U.S. Ventures Management LLC ($27.27M), Vanguard Group Inc. ($17.99M), BVF Inc. IL ($17.92M), Braidwell LP ($15.28M), and Kingdon Capital Management L.L.C. ($14.59M).Learn more on JSPR's institutional investors.

What percentage of Jasper Therapeutics stock is owned by institutional investors?

79.85% of Jasper Therapeutics stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings.

Which institutional investors have been buying Jasper Therapeutics stock?

Of the 53 institutional investors that purchased Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($9.90M), Carlyle Group Inc. ($8.76M), Opaleye Management Inc. ($3.99M), Kingdon Capital Management L.L.C. ($3M), Ally Bridge Group NY LLC ($2.70M), Qiming U.S. Ventures Management LLC ($2.67M), and RTW Investments LP ($2.33M).

How much institutional buying is happening at Jasper Therapeutics?

Institutional investors have bought a total of 37,964,884 shares in the last 24 months. This purchase volume represents approximately $641.16M in transactions.

Which Jasper Therapeutics major shareholders have been selling company stock?

Of the 18 institutional investors that sold Jasper Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Carlyle Group Inc. ($7.70M), Qiming U.S. Ventures Management LLC ($7.59M), Opaleye Management Inc. ($3.55M), Vanguard Group Inc. ($3.48M), Kingdon Capital Management L.L.C. ($3.04M), Ally Bridge Group NY LLC ($348.37K), and Woodline Partners LP ($249.43K).

How much institutional selling is happening at Jasper Therapeutics?

Institutional investors have sold a total of 26,427,138 shares in the last 24 months. This volume of shares sold represents approximately $765.54M in transactions.



This page (NASDAQ:JSPR) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners